Preclinical pharmacology celiprolol cardioselective beta-adrenergic antagonist mild vasodilator Celiprolol new antihypertensive agent new generation beta-blockers cardioselective beta-adrenergic antagonism mild vasodilation vasoselective beta-adrenergic agonism Results animal studies celiprolol potency similar propranolol atenolol cardioselectivity atenolol Celiprolol bronchoconstriction propranolol-resistant bronchodilatory properties cats compound vascular smooth muscle propranolol-sensitive fashion mechanism beta beta results selective downregulation beta number response tissue culture peripheral tissue celiprolol-treated volunteers decreases beta concomitant treatment propranolol Celiprolol devoid cardiac depressant activity fact cardiostimulatory actions cardiostimulation beta beta-blocking doses propranolol model severe myocardial ischemia celiprolol ischemia-induced myocardial acidosis regional segment function results suggestive myocardial protection summary celiprolol distinguishes beta-blockers virtue cardioselectivity vasorelaxation beta lack bronchoconstriction cardiodepression properties animal studies clinical trials 